Attovia Therapeutics Statistics
Total Valuation
ATTO has a market cap or net worth of $690.70 million. The enterprise value is $298.60 million.
| Market Cap | 690.70M |
| Enterprise Value | 298.60M |
Important Dates
The last earnings date was Monday, November 9, 2026, after market close.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATTO has 45.65 million shares outstanding. The number of shares has increased by 198.23% in one year.
| Current Share Class | 45.65M |
| Shares Outstanding | 45.65M |
| Shares Change (YoY) | +198.23% |
| Shares Change (QoQ) | +593.08% |
| Owned by Insiders (%) | 1.58% |
| Owned by Institutions (%) | 14.69% |
| Float | 26.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 479.66 |
| Forward PS | n/a |
| PB Ratio | 1.74 |
| P/TBV Ratio | 1.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 207.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 34.66, with a Debt / Equity ratio of 0.01.
| Current Ratio | 34.66 |
| Quick Ratio | 33.93 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -21.40% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $32,727 |
| Profits Per Employee | -$1.79M |
| Employee Count | 44 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 17.53 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 44.16 |
| Average Volume (20 Days) | 269,970 |
Short Selling Information
The latest short interest is 1.59 million, so 3.48% of the outstanding shares have been sold short.
| Short Interest | 1.59M |
| Short Previous Month | 1.45M |
| Short % of Shares Out | 3.48% |
| Short % of Float | 6.05% |
| Short Ratio (days to cover) | 3.01 |
Income Statement
In the last 12 months, ATTO had revenue of $1.44 million and -$78.87 million in losses. Loss per share was -$7.49.
| Revenue | 1.44M |
| Gross Profit | -70.93M |
| Operating Income | -85.62M |
| Pretax Income | -78.87M |
| Net Income | -78.87M |
| EBITDA | -84.65M |
| EBIT | -85.62M |
| Loss Per Share | -$7.49 |
Balance Sheet
The company has $395.94 million in cash and $3.84 million in debt, with a net cash position of $392.10 million or $8.59 per share.
| Cash & Cash Equivalents | 395.94M |
| Total Debt | 3.84M |
| Net Cash | 392.10M |
| Net Cash Per Share | $8.59 |
| Equity (Book Value) | 397.74M |
| Book Value Per Share | 8.71 |
| Working Capital | 392.85M |
Cash Flow
In the last 12 months, operating cash flow was -$77.95 million and capital expenditures -$430,000, giving a free cash flow of -$78.38 million.
| Operating Cash Flow | -77.95M |
| Capital Expenditures | -430,000 |
| Depreciation & Amortization | 967,000 |
| Net Borrowing | 453,000 |
| Free Cash Flow | -78.38M |
| FCF Per Share | -$1.72 |
Margins
| Gross Margin | n/a |
| Operating Margin | -5,945.49% |
| Pretax Margin | -5,477.22% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATTO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -198.23% |
| Shareholder Yield | -198.23% |
| Earnings Yield | -49.50% |
| FCF Yield | -11.35% |
Analyst Forecast
The average price target for ATTO is $43.20, which is 185.53% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $43.20 |
| Price Target Difference | 185.53% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |